SPDR S&P Biotech ETF (NYSEARCA:XBI) Hits New 1-Year High – Here’s What Happened

SPDR S&P Biotech ETF (NYSEARCA:XBI)’s stock price hit a new 52-week high during mid-day trading on Monday . The company traded as high as $161.20 and last traded at $159.98, with a volume of 882429 shares trading hands. The stock had previously closed at $160.46.

SPDR S&P Biotech ETF Stock Performance

The company has a market capitalization of $10.76 billion, a P/E ratio of 11.47 and a beta of 0.82. The stock has a 50 day moving average price of $137.41 and a 200 day moving average price of $130.02.

Institutional Trading of SPDR S&P Biotech ETF

Several hedge funds have recently added to or reduced their stakes in the stock. Compound Planning Inc. boosted its stake in SPDR S&P Biotech ETF by 0.7% in the first quarter. Compound Planning Inc. now owns 10,889 shares of the exchange traded fund’s stock valued at $1,391,000 after acquiring an additional 75 shares during the last quarter. Dynamic Wealth Strategies LLC raised its holdings in shares of SPDR S&P Biotech ETF by 3.8% in the 4th quarter. Dynamic Wealth Strategies LLC now owns 2,201 shares of the exchange traded fund’s stock worth $268,000 after purchasing an additional 80 shares during the period. Capital Investment Advisory Services LLC lifted its stake in SPDR S&P Biotech ETF by 4.0% in the fourth quarter. Capital Investment Advisory Services LLC now owns 2,123 shares of the exchange traded fund’s stock valued at $259,000 after purchasing an additional 81 shares during the last quarter. PeakShares LLC grew its holdings in SPDR S&P Biotech ETF by 5.2% during the first quarter. PeakShares LLC now owns 1,684 shares of the exchange traded fund’s stock valued at $215,000 after purchasing an additional 84 shares during the period. Finally, Commerce Bank lifted its position in shares of SPDR S&P Biotech ETF by 2.8% during the 4th quarter. Commerce Bank now owns 3,260 shares of the exchange traded fund’s stock valued at $397,000 after buying an additional 90 shares during the last quarter.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.